Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Bipolar Disorder (bd) Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

7 recruiting trials for Bipolar Disorder (bd). Eligibility criteria explained in plain English.

TrialFinderData lists 7 Bipolar Disorder (bd) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by King's College London (1), University of Sao Paulo (1), First Affiliated Hospital of Zhejiang University (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Flow FL-100 tDCS headset (device, 1 trial), followed by Nutritional intervention, Temporal Interference Stimulation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
7
Total Trials
7
Recruiting Now
0
Phase 3 Trials
7
Sponsors

Track Bipolar Disorder (bd) trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07556692

A Study of Home-use Brain Stimulation to Treat Bipolar Depression

Bipolar depression is a long-lasting and disabling condition, and many people continue to experience depressive symptoms despite standard treatments. Transcranial direct current...

Sponsor: King's College LondonEnrolling: 2121 location
RECRUITINGNCT06488573

PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder

Individuals with Bipolar Disorder (BD) have twice the risk of being affected by metabolic comorbidities and a 1.8-fold increased risk of mortality from cardiovascular diseases...

Sponsor: University of Sao PauloEnrolling: 881 location
RECRUITINGNCT07589647

Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic...

This study aims to stabilize the patients with bipolar disorder (BD) comorbid with obesity in the stable phase by using temporal interference stimulation (TIS ) intervention. It...

Sponsor: First Affiliated Hospital of Zhejiang UniversityEnrolling: 701 location
RECRUITINGNCT06729541

Development and Application of Precision Treatment Strategies for Common Mental Disorders

Schizophrenia (SCH), major depressive disorder (MDD), and bipolar disorder (BPD) are prevalent, disabling psychiatric conditions that not only cause significant suffering for...

Sponsor: Peking UniversityEnrolling: 6001 location
RECRUITINGNCT07306468

Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and...

Sponsor: Çankırı Karatekin UniversityEnrolling: 1501 location
RECRUITINGNCT07213492

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

People with bipolar disorder (BD) are at high risk of relapse following hospital discharge, partly due to a lack of BD-specific expertise and resources within community services...

Sponsor: McMaster UniversityEnrolling: 101 location
RECRUITINGNCT07404085

Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations

The aim of this clinical trial is to investigate the effects of a three-week virtual reality-based cognitive remediation training (VR-CRT) programme in combination with daily...

Sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalEnrolling: 1601 location

Frequently Asked Questions

There are currently 7 clinical trials for Bipolar Disorder (bd), with 7 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Bipolar Disorder (bd), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Bipolar Disorder (bd), representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.